Meloxicam | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meloxicam
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Meloxicam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 22 USDMF, 15 CEP/COS, 7 JDMF, 15 EU WC, 27 KDMF, 20 NDC API, 34 Listed Suppliers, $ API Reference Price

56 API Suppliers
22 USDMF
15 CEP/COS
7 JDMF
15 EU WC
27 KDMF
20 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

324 FDF Dossiers, 62 FDA Orange Book, 69 Europe, 36 Canada, 34 Australia, 44 South Africa, 79 Listed Dossiers

324 FDF Dossiers
62 FDA Orange Book
69 Europe
36 Canada
34 Australia
44 South Africa
79 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 7.5MG, SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 7.5MG/5ML

TABLET;ORAL - 15MG
TABLET;ORAL - 7.5MG
SOLUTION;INTRAVENOUS - 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 7.5MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 4 ACG Worldwide, 7 Actylis, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 7 DFE Pharma, 7 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qualicaps, 27 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

74 Fillers, Diluents & Binders, 41 Disintegrants & Superdisintegrants, 30 Direct Compression, 26 Granulation, 24 Thickeners and Stabilizers, 20 Lubricants & Glidants, 17 Coating Systems & Additives, 16 Taste Masking, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 12 Controlled & Modified Release, 12 Film Formers & Plasticizers, 10 Solubilizers, 9 Parenteral, 8 Empty Capsules, 7 Topical, 5 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

74 Fillers, Diluents & Binders
41 Disintegrants & Superdisintegrants
30 Direct Compression
26 Granulation
24 Thickeners and Stabilizers
20 Lubricants & Glidants
17 Coating Systems & Additives
16 Taste Masking
14 Chewable & Orodispersible Aids
14 Co-Processed Excipients
12 Controlled & Modified Release
12 Film Formers & Plasticizers
10 Solubilizers
9 Parenteral
8 Empty Capsules
7 Topical
5 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 47 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 57 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
57 Finished Drug Prices
1 Annual Reports

MARKET PLACE

34 APIs, 2 FDF Dossiers, 1 Intermediates

34 APIs
2 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

81 US Patents, 8 US Exclusivities, 2 Health Canada Patents

81 US Patents
8 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 6 USP, 6 Others

5 EDQM
6 USP
6 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 94 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Boehringer Ingelheim (Canada) Ltd.

02 1Boehringer lngelheim Animal Health Canada Inc.

filter Patent Reset all filters

2 All

01 12326048

02 12414063

filter Product Reset all filters

2 All

01 2Meloxicam

filter Dosage Reset all filters

2 All

01 1Oral supension

02 1Solution for injection

filter Exp Date Reset all filters

2 All

01 12019-03-23

02 12021-06-19

Product Main Page

01

Boehringer lngelheim Animal Health Canada ...

Meloxicam

The Generic Rx Session

Not Confirmed

Boehringer lngelheim Animal Health ...

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-19

Date Granted : 2008-06-17

Brand Name : METACAM

Patent Number : 2414063

Filing Date : 2001-06-19

Strength per Unit : 20 mg / mL

Dosage Form : Solution for injection

Human Or VET : Veterinary

Route of Administration : Intravenous, Subcutaneous

Patent Expiration Date : 2021-06-19

Date Granted : 2008-06-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Boehringer Ingelheim (Canada) Ltd.

Meloxicam

The Generic Rx Session

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-03-23

Date Granted : 2008-08-12

Brand Name : METACAM

Patent Number : 2326048

Filing Date : 1999-03-23

Strength per Unit : 0.5 mg/mL

Dosage Form : Oral supension

Human Or VET : Veterinary

Route of Administration : Oral

Patent Expiration Date : 2019-03-23

Date Granted : 2008-08-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!